Voyager Therapeutics Inc (NASDAQ:VYGR)
| 7.70 Delayed Data As of Sep 26 |  +0.13 / +1.72%Today’s Change | 4.77 Today|||52-Week Range 14.34 | +26.23% Year-to-Date |
Latest VYGR News | Press Releases
No recent news for Voyager Therapeutics Inc.
Today’s Trading
| Previous close | 7.55 |
| Today’s open | 7.73 |
| Day’s range | 7.60 - 7.92 |
| Volume | 222,840 |
| Average volume (3 months) | 481,305 |
| Market cap | $338.0M |
Data as of 3:59pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | +35.99% |
| Earnings growth (this year) | +188.84% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +9.33% |
| P/E ratio | 3.5 |
| Price/Sales | 5.72 |
| Price/Book | 5.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QUREUniqure NV | +0.08 | +1.17% |
| PGENPrecigen Inc | +0.06 | +4.48% |
| BLUEbluebird bio Inc | +0.05 | +1.65% |
| SIGASIGA Technologies In... | +0.12 | +2.45% |
Data as of 3:59pm ET, 09/26/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $40.9M |
| Annual profit (last year) | -$46.4M |
| Net profit margin | -113.45% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
